Search

everythinglearnresearchcommunity

for

Search:↓

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Young women with PCOS and no other heart risk factors have normal heart function.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

SHBG may be a useful early indicator and treatment target for PCOS.